Belgian Healthcare Services Stock News

Solvay (ENXTBR:SOLB) has drawn attention after confirming its 2025 guidance even as tariff issues affect its Brazilian business. The company also approved a stable interim dividend and reported stronger net profit, sparking investor interest. See our latest analysis for Solvay. Momentum around Solvay has been choppy this year, with the company’s confirmation of 2025 guidance and recent profit beat offering reassurance after a challenging stretch. While the share price is down nearly 14%...

Proximus (ENXTBR:PROX) is drawing increased attention as its Q3 2025 earnings call approaches on November 7. This event typically offers investors important updates regarding the company’s recent performance and future direction. See our latest analysis for Proximus. Proximus has experienced a volatile period recently, with a 7.24% decline in share price over the past week and an 8.05% decrease over the last month. Despite this recent decline, the share price is still up 35.72% year-to-date,...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

argenx (ENXTBR:ARGX) shares have climbed around 6% over the past month, catching the interest of investors looking for signs of sustainable momentum. The stock’s double-digit annual revenue and earnings growth adds to the intrigue as the company pushes forward in the biotech space. See our latest analysis for argenx. Momentum has been building for argenx, with a 28.5% share price return over the past three months and a stellar one-year total shareholder return of 31.7%. Investors seem to be...

Solvay SA recently reported its third quarter and nine-month 2025 results, revealing sales of €1,011 million and nine-month sales of €3.16 billion, both lower than the prior year, but with third quarter net income rising to €34 million from €19 million a year ago. An interesting aspect is that despite lower sales and revenue figures, Solvay managed to increase earnings per share and net income in the third quarter compared to the same period last year, signaling potential cost controls or...

With its stock down 14% over the past three months, it is easy to disregard Colruyt Group (EBR:COLR). However, a closer...

Care Property Invest (ENXTBR:CPINV) saw net profit margins leap to 53.5% from just 4.2% a year ago, while earnings growth soared to an eye-catching 1241.2% after five years of average declines of -15.2% per year. Looking forward, the company is forecasting annual earnings growth of 10.1% and revenue growth of 2%, trailing behind broader Belgian market peers. For investors, recent results showcase an impressive turnaround in profitability, but future gains may depend on how these improvements...

Anheuser-Busch InBev (ENXTBR:ABI) stock has drawn attention lately, as investors weigh its recent momentum and outlook. The company's results over the past month highlight steady progress as it navigates a competitive global beverage market. See our latest analysis for Anheuser-Busch InBev. After a solid 8.6% share price gain over the past month, Anheuser-Busch InBev continues to show resilience. Year-to-date momentum has pushed its stock higher, and a 1-year total shareholder return of 4.5%...

Key Insights The considerable ownership by sovereign wealth funds in bpost/SA indicates that they collectively have a...

Wondering if argenx is really worth its soaring share price? You are not alone, especially as buzz grows around how this stock stacks up against market expectations. argenx has delivered an impressive 30.8% return over the past year and is up 18.4% year-to-date, drawing fresh attention from growth-focused investors. Fueling recent price moves, the company has been in the spotlight due to positive new drug developments and regulatory wins that reinforce the long-term growth story behind the...

As the European market navigates a mixed landscape, with the STOXX Europe 600 Index recently pulling back after reaching new highs and interest rate expectations from the ECB remaining steady, investors are increasingly focused on identifying opportunities among undervalued stocks. In such an environment, a good stock is often characterized by its potential to trade below its estimated intrinsic value, offering room for appreciation as market conditions evolve.

Key Insights The considerable ownership by retail investors in Financière de Tubize indicates that they collectively...

If you have ever wondered whether Solvay’s current share price offers genuine value or just more volatility, you are not alone. This is the right place for answers. The stock has slipped by 3.5% over the past week and is now down 27.9% over the past year. However, it still shows 52% returns over three years and 79.2% over the past five years. Recent headlines have focused on Solvay’s major restructuring and its shift of strategic priorities after splitting into two companies, which has...

As the European markets navigate a period of mixed performance, with the pan-European STOXX Europe 600 Index recently pulling back after hitting a fresh high, investors are keenly observing opportunities that may arise amidst shifting economic conditions. Penny stocks, despite their somewhat outdated moniker, continue to capture interest for their potential to offer surprising value and growth. In this article, we explore three European penny stocks that stand out for their financial strength...

Stock pickers are generally looking for stocks that will outperform the broader market. And in our experience, buying...

In late October 2025, Anheuser-Busch InBev announced third-quarter results showing sales of US$15.13 billion and net income of US$1.05 billion, alongside a new US$6 billion share buyback program and an interim dividend of €0.15 per share. The share repurchase initiative and dividend affirmation signal robust capital return plans, even as the company reported profit pressure from lower beer volumes and regional market weakness. We'll assess how the large-scale buyback underscores...

With a median price-to-sales (or "P/S") ratio of close to 0.7x in the Chemicals industry in Belgium, you could be...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...

Syensqo (ENXTBR:SYENS) shares moved modestly today, catching the eye of investors who are watching for shifts in valuation. The stock’s recent performance offers an interesting angle for those tracking the materials sector. See our latest analysis for Syensqo. Syensqo’s share price has shown some resilience lately, notching a 5.9% gain over the past month and a modest 1-year total shareholder return of 0.6%. While momentum has been somewhat uneven, today’s movement suggests that investors are...

Wondering if now is the right time to get into Anheuser-Busch InBev? You are not alone, as interest around this iconic brewer keeps bubbling up in investor circles. The stock has caught a mild tailwind lately, recording a 4.4% gain over the last month and an 8.5% rise year-to-date. Its one-year return remains slightly negative at -2.9%. These recent moves come as global headlines focus on consumer trends in beer and the company’s brand strategy revamp. This has fueled both optimism and...

Melexis NV reported its third quarter 2025 results, showing sales of €215.29 million and net income of €27.53 million, both significantly lower than the same period a year ago. The contraction in sales and profit indicates the company may be encountering operational or market challenges over the year so far. We’ll examine how reduced earnings for the quarter are influencing Melexis’ investment narrative and outlook for operational momentum. The end of cancer? These 29 emerging AI stocks are...

DEME Group (ENXTBR:DEME) has won Brazil’s inaugural auction for a port access channel concession, in partnership with FTS Participacoes Societarias. This 25-year contract covers operations and expansion at the vital Port of Parana. See our latest analysis for DEME Group. DEME Group’s announcement of the major Brazilian port concession appears to have reignited market attention, with a strong 6.6% share price return over the past month after a mixed year. While year-to-date returns remain...

Proximus PLC's ( EBR:PROX ) price-to-earnings (or "P/E") ratio of 4.2x might make it look like a strong buy right now...

Anheuser-Busch InBev (ENXTBR:ABI) posted a net profit margin of 12.2% for the most recent period, a jump from last year’s 9.9%. Over the past five years, the company has averaged 24.5% annual earnings growth, with current-year earnings up 20%. Although this is not as rapid as previous years, it is still growing. With analysts forecasting another 10.03% per year in earnings growth and the stock trading well below consensus fair value estimates, investors are likely to see the current...